Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
KALVISTA PHARMACEUTICALS INC
About KALV
KalVista Pharmaceuticals, Inc. is a global pharmaceutical company. It has discovered and developed EKTERLY, an oral on-demand treatment for hereditary angioedema (HAE). EKTERLY is formulated as a film-coated tablet for oral administration, with high bioavailability and selectivity for plasma kallikrein, enabling maximal dosing and a rapid decline in edema effectors that cause swelling during an HAE attack. Its clinical trials include KONFIDENT-KID, KONFIDENT-S and KONFIDENT. KONFIDENT-KID is an open-label clinical trial of sebetralstat for on-demand treatment of HAE attacks in pediatric patients. KONFIDENT-KID collects safety, pharmacokinetic and efficacy data for each patient for up to one year and features a proprietary pediatric orally disintegrating tablet formulation of sebetralstat. KONFIDENT-S study is an open-label extension trial to evaluate the long-term safety of sebetralstat for on-demand treatment of HAE attacks in adolescent and adult patients with type I or type II HAE.
Find out what a historical investment in KALVISTA PHARMACEUTICALS INC would be worth today using our KALV stock calculator.
Market Capitalisation
$1.44B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.54M
High today
$27.00
Low today
$26.98
Open price
$26.99
52-week high
$26.99
52-week low
$9.83
Ready to start your investing journey with Stake?
Open an accountHow do I buy KALV shares in Australia?
Buying KALV shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in KALVISTA PHARMACEUTICALS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KALV
What is the ticker symbol of KALVISTA PHARMACEUTICALS INC?
The ticker symbol for KALVISTA PHARMACEUTICALS INC is KALV.
How much is one share of KALV?
One share of KALV is valued at $26.99 as of 10 June 2026.
What is the market capitalisation of KALVISTA PHARMACEUTICALS INC KALV?
As of 10 June 2026 KALVISTA PHARMACEUTICALS INC has a market cap of $1.44B.
What is the 52-week high for KALVISTA PHARMACEUTICALS INC stock?
The KALVISTA PHARMACEUTICALS INC 52-week high stock price is $26.99.
What is the 52-week low for KALVISTA PHARMACEUTICALS INC stock?
The KALVISTA PHARMACEUTICALS INC 52-week low stock price is $9.83.
Can I buy KALV shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KALV shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KALV on Stake
- Buy KALV from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KALV from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KALV related stocks